Skip to main content
. Author manuscript; available in PMC: 2010 Dec 21.
Published in final edited form as: Hum Immunol. 1986 Jun;16(2):182–199. doi: 10.1016/0198-8859(86)90047-9

TABLE 3. Proliferative responses vs. histology.

Liver biopsy Days in culture Proliferative responses (CPM ± S.D.) Cause of graft dysfunction
Background Exogenous IL-2 Donor stimulated
1.7A 12 452 ± 62 19,581 ± 1,536 27,472 ± 2,741 moderate rejection
3.32A 14 2,097 ± 1,608 13,413 ± 1,395 17,120 ± 1,119a mild rejection
5.300B 12 825 ± 92 8,614 ± 365 9,404 ± 1,466 mild rejection
6.73A 10 303 ± 65 15,870 ± 908 16,223 ± 827a severe rejection
7.5A 14 858 ± 114 11,867 ± 1,453 9,334 ± 1,757 moderate rejection
8.9A 9 708 ± 60 2,556 ± 50 4,008 ± 380 severe rejection
8.13A 7 916 ± 191 15,215 ± 71 27,738 ± 1,989 moderate rejection
9.9A 12 222 ± 23 7,730 ± 306 1,8941 ± 959 severe rejection
9.11B 12 2,210 ± 335 34,678 ± 1,556 22,896 ± 1,900 moderate rejection
9.39B 8 1,211 ± 152 9,299 ± 93 21,547 ± 1,544a severe rejection
10.59B 4 614 ± 194 30,713 ± 1,209 18,067 ± 911 severe rejection
13.5A 10 939 ± 75 14,981 ± 884 8,448 ±115 early rejection?
13.28B 7 4,447 ± 194 55,395 ± 1,694 125,294 ± 1,972 ischemic injury
2.16A 21 257 ± 35 10,189 ± 744 2,774 ± 1,119a ischemic injury
4.12A 10 411 ± 112 8,536 ± 170 728 ± 117 mild rejection
11.3A 15 1,118 ± 11 24,420 ± 606 2,690 ± 1,454 ischemic injury
12.3A 18 631 ± 145 25,755 ± 3,149 865 ± 442 yeast infection
14.30A 21 187 ± 5 9,775 ± 15 593 ± 64 moderate rejection
a

Donor cell not available, maximum stimulation with panel cell.